News & Events
News & Events
[inews24] [Vaccine War] ⑩ Chong Kun Dang Pharmaceutical Corp. is putting the utmost effort into Phase 3 clinical trials of COVID-19 therapeutics… "To develop the 2nd approved COVID-19 drug in Korea”
2021-09-16
Clinical trials for the development of nafamostat into COVID-19 therapeutics, based on the results of drug repositioning research carried out by Institut Pasteur Korea, are actively underway in Korea and abroad.
+ + + + +inews24 (2021.9.16)
[Vaccine War] ⑩ Chong Kun Dang Pharmaceutical Corp. is putting the utmost effort into Phase 3 clinical trials of COVID-19 therapeutics… "To develop the 2nd approved COVID-19 drug in Korea”
Go to the Article >>